Abbvie, Cerevel Therapeutics to file US antitrust paperwork within 10 days
MLex Summary: Abbvie and Cerevel Therapeutics are expected to file US antitrust paperwork within 10 days from their Dec. 7 merger agreement, according to a securities filing. The companies said that...To view the full article, register now.
Already a subscriber? Click here to view full article